NL7100529A - - Google Patents

Info

Publication number
NL7100529A
NL7100529A NL7100529A NL7100529A NL7100529A NL 7100529 A NL7100529 A NL 7100529A NL 7100529 A NL7100529 A NL 7100529A NL 7100529 A NL7100529 A NL 7100529A NL 7100529 A NL7100529 A NL 7100529A
Authority
NL
Netherlands
Application number
NL7100529A
Other versions
NL165217C (nl
NL165217B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7100529A publication Critical patent/NL7100529A/xx
Publication of NL165217B publication Critical patent/NL165217B/xx
Application granted granted Critical
Publication of NL165217C publication Critical patent/NL165217C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL7100529.A 1970-04-29 1971-01-14 Werkwijze voor het bereiden van een vaccin voor het immuniseren van pluimvee tegen de ziekte van marek. NL165217C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3306070A 1970-04-29 1970-04-29

Publications (3)

Publication Number Publication Date
NL7100529A true NL7100529A (de) 1971-11-02
NL165217B NL165217B (nl) 1980-10-15
NL165217C NL165217C (nl) 1981-03-16

Family

ID=21868356

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7100529.A NL165217C (nl) 1970-04-29 1971-01-14 Werkwijze voor het bereiden van een vaccin voor het immuniseren van pluimvee tegen de ziekte van marek.

Country Status (21)

Country Link
US (1) US3642574A (de)
JP (1) JPS4841534B1 (de)
AT (2) AT317606B (de)
BE (1) BE766492A (de)
BR (1) BR7102066D0 (de)
CA (1) CA934295A (de)
CH (1) CH565863A5 (de)
CS (1) CS191868B2 (de)
DE (1) DE2120929B2 (de)
DK (1) DK133311C (de)
ES (1) ES390698A1 (de)
FR (1) FR2092112B1 (de)
GB (2) GB1316168A (de)
HU (1) HU162835B (de)
IE (1) IE35138B1 (de)
IL (1) IL36329A (de)
IT (1) IT1045525B (de)
NL (1) NL165217C (de)
PL (1) PL76295B1 (de)
YU (1) YU35785B (de)
ZA (1) ZA711382B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3965258A (en) * 1974-11-30 1976-06-22 Merck & Co., Inc. Process for production of vaccines
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
JPS6327437A (ja) * 1986-07-17 1988-02-05 Chemo Sero Therapeut Res Inst 鶏伝染病生ワクチン
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
US6303129B1 (en) 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
WO2010008528A2 (en) * 2008-07-18 2010-01-21 The Texas A&M University System Marek's disease virus vaccine compositions and methods of using thereof
AP2014007955A0 (en) 2012-03-22 2014-09-30 Merial Ltd Modified marek's disease virus, and vaccines made therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens

Also Published As

Publication number Publication date
AT317606B (de) 1974-09-10
BE766492A (fr) 1971-09-16
IE35138B1 (en) 1975-11-26
NL165217C (nl) 1981-03-16
GB1317710A (en) 1973-05-23
PL76295B1 (de) 1975-02-28
HU162835B (de) 1973-04-28
IL36329A (en) 1975-04-25
FR2092112A1 (de) 1972-01-21
BR7102066D0 (pt) 1973-03-13
DE2120929A1 (de) 1971-11-18
CS191868B2 (en) 1979-07-31
NL165217B (nl) 1980-10-15
IL36329A0 (en) 1971-05-26
DK133311C (da) 1976-09-20
GB1316168A (en) 1973-05-09
YU35785B (en) 1981-06-30
US3642574A (en) 1972-02-15
CA934295A (en) 1973-09-25
JPS4841534B1 (de) 1973-12-07
CH565863A5 (de) 1975-08-29
IT1045525B (it) 1980-05-10
AT317421B (de) 1974-08-26
IE35138L (en) 1971-10-29
FR2092112B1 (de) 1974-09-06
ZA711382B (en) 1972-11-29
YU62571A (en) 1980-10-31
ES390698A1 (es) 1973-07-01
DE2120929B2 (de) 1979-06-28
DK133311B (da) 1976-04-26

Similar Documents

Publication Publication Date Title
AR204384A1 (de)
ATA96471A (de)
AU2044470A (de)
AU1146470A (de)
AU1833270A (de)
AU2017870A (de)
AU1716970A (de)
AU1336970A (de)
AU2085370A (de)
AU2130570A (de)
AU1326870A (de)
AR195465A1 (de)
ATA672271A (de)
AU1974970A (de)
AU1235770A (de)
AU1247570A (de)
AU1277070A (de)
AU1832970A (de)
AU2144270A (de)
AU1841070A (de)
AU1872870A (de)
AU1879170A (de)
AU1881070A (de)
AU1918570A (de)
AU1943370A (de)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee